AMAG Pharmaceuticals, Inc. (AMAG): Price and Financial Metrics


AMAG Pharmaceuticals, Inc. (AMAG)

Today's Latest Price: $8.87 USD

0.24 (2.78%)

Updated Jun 5 3:51pm

Add AMAG to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

AMAG Stock Summary

  • AMAG's went public 34.01 years ago, making it older than 92.64% of listed US stocks we're tracking.
  • In terms of twelve month growth in earnings before interest and taxes, Amag Pharmaceuticals Inc is reporting a growth rate of 685.48%; that's higher than 97.86% of US stocks.
  • Revenue growth over the past 12 months for Amag Pharmaceuticals Inc comes in at -25.86%, a number that bests merely 7.48% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Amag Pharmaceuticals Inc are EVH, SANW, NBEV, HUSA, and GVP.
  • AMAG's SEC filings can be seen here. And to visit Amag Pharmaceuticals Inc's official web site, go to www.amagpharma.com.
AMAG Daily Price Range
AMAG 52-Week Price Range

AMAG Stock Price Chart More Charts


AMAG Price/Volume Stats

Current price $8.87 52-week high $13.53
Prev. close $8.63 52-week low $4.41
Day low $8.85 Volume 578,391
Day high $9.30 Avg. volume 706,044
50-day MA $7.56 Dividend yield N/A
200-day MA $9.63 Market Cap 304.00M

AMAG Pharmaceuticals, Inc. (AMAG) Company Bio


AMAG Pharmaceuticals has a diverse portfolio of products in the areas of maternal health, anemia management and cancer supportive care. The company was founded in 1981 and is based in Waltham, Massachusetts.


AMAG Latest News Stream


Event/TimeNews Detail
Loading, please wait...

AMAG Latest Social Stream


Loading social stream, please wait...

View Full AMAG Social Stream

Latest AMAG News From Around the Web

Below are the latest news stories about Amag Pharmaceuticals Inc that investors may wish to consider to help them evaluate AMAG as an investment opportunity.

Edited Transcript of AMAG earnings conference call or presentation 11-May-20 12:00pm GMT

Q1 2020 AMAG Pharmaceuticals Inc Earnings Call

Yahoo | June 3, 2020

AMAG Pharmaceuticals to Participate in Jefferies Virtual Global Healthcare Conference

AMAG Pharmaceuticals, Inc. (AMAG) today announced that management will participate at the Jefferies Virtual Global Healthcare Conference on Wednesday, June 3, 2020 at 4:00 p.m. Eastern Time. A live audio webcast of the virtual event will be accessible through the Investors section of the company’s website at www.amagpharma.com. AMAG is a pharmaceutical company focused on bringing innovative products to patients with unmet medical needs.

Yahoo | May 27, 2020

AMAG Pharmaceuticals Completes Sale of its Rights to Intrarosa® to Millicent Pharma for up to $125 Million

AMAG Pharmaceuticals, Inc. (AMAG) today announced it has completed the sale of its rights to Intrarosa® (prasterone) to Millicent Pharma Limited, a global pharmaceutical company formed by the Millicent Pharma management team and The Carlyle Group in 2018 that specializes in women’s health and menopause-related conditions, for up to $125 million, including upfront fixed consideration of $20 million and contingent, sales-based milestone payments of up to $105 million. “As mentioned in our first quarter earnings release, the sale of Intrarosa is an important step in our strategic evolution,” said Scott Myers AMAG’s president and chief executive officer.

Yahoo | May 21, 2020

AMAG Pharmaceuticals (AMAG) Reports Q1 Loss, Beats on Revenues

AMAG Pharmaceuticals' (AMAG) loss narrows year over year while sales top estimates in the first quarter of 2020. The company scraps 2020 outlook due to the plaguing pandemic effect.

Zacks Investment Research | May 12, 2020

AMAG Pharmaceuticals Inc (AMAG) Q1 2020 Earnings Call Transcript

At this time I would like to welcome everyone to the AMAG Pharmaceuticals First Quarter 2020 Earnings Call. Good morning and welcome to the AMAG Pharmaceuticals conference call to discuss our first quarter 2020 financial results. Please be reminded that remarks made during this call may include forward-looking statements pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995.

Yahoo | May 11, 2020

Read More 'AMAG' Stories Here

AMAG Price Returns

1-mo 10.05%
3-mo 15.49%
6-mo -19.87%
1-year -8.08%
3-year -47.04%
5-year -87.60%
YTD -27.12%
2019 -19.88%
2018 14.64%
2017 -61.93%
2016 15.27%
2015 -29.16%

Continue Researching AMAG

Want to see what other sources are saying about Amag Pharmaceuticals Inc's financials and stock price? Try the links below:

Amag Pharmaceuticals Inc (AMAG) Stock Price | Nasdaq
Amag Pharmaceuticals Inc (AMAG) Stock Quote, History and News - Yahoo Finance
Amag Pharmaceuticals Inc (AMAG) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8664 seconds.